Health is our business
1 Feb/ 0 Comment/ 291 Hits/
Behestan Darou Firm/ Amgen Company were the organizer of the educational webinar in Mashhad University of Medical Sciences on the topic of new osteoporosis treatments on June 19 with 2 retraining points.
The purpose of the program was to introduce new drug therapies in osteoporosis (antiseptics) and the importance of assessing BMD and patients' management.
The keynote speakers were three prominent professors of rheumatology and neurosurgery. Also, a presentation on Prolia along with related articles and its effect on osteoporosis patients was presented by Dr. Borkhori, a product specialist of Amgen.